MedTrace Logo

the Effect of Doctor-nurse-patient Cooperative Analgesic Linkage Program on Movement Evoked Pain

NCT03823846 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-02-12

No results posted yet for this study

Summary

1. To establish doctor-nurse-patient cooperative analgesic linkage program.
2. Evaluate the effect of doctor-nurse-patient cooperative analgesic linkage program on movement evoked pain after laparotomy for patients with hepatobiliary and pancreatic disease through quasi-experimental study.

Conditions

  • Pain, Postoperative
  • Anaplasia

Interventions

DRUG

Routine Dezocine injection

Dezocine 10mg were intramuscular injected at 8:00am, 4:00pm and 12:00pm.

DRUG

Adjusted Dezocine injection

Dezocine 10mg were intramuscular injected at at 6:00am, 2:00pm and 10:00pm.

DRUG

Routine Dynastat or Flurbiprofen Axetil jinjection

Dynastat 40mg or Flurbiprofen Axetil 50mg were administrated intravenously at 9:00am, 4:00pm and 12:00pm.

DRUG

Adjusted Dynastat or Flurbiprofen Axetil jinjection

Dynastat 40mg or Flurbiprofen Axetil 50mg were administrated intravenously at at 6:00am, 2:00pm and 10:00pm.

OTHER

postoperative rehabilitation

Rehabilitation was conducted at 8:00am and 2:00pm.

DRUG

normal analgesia pump administration

Dose of analgesia pump was added if needed.

DRUG

adjusted analgesia pump administration

Dose of analgesia pump was added if needed. Add one dose of analgesia pump 10 minutes before rehabilitation.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Caijuan Xu, master · Second Affiliated Hospital, School of Medicine, Zhejiang University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2020-08-01
Completion
2020-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03823846 on ClinicalTrials.gov